Learn how informed consent works under Turkish law, when lack of consent leads to liability, what doctors must disclose, and how patients can claim damages in Turkey.
Informed consent is one of the central pillars of Turkish Medical Malpractice Law. In Turkey, medical treatment is not viewed merely as a technical healthcare service. It is also a legal interference with the patient’s bodily integrity, autonomy, privacy, and right to make decisions about his or her own health. For that reason, Turkish law does not treat consent as a routine signature collected before surgery or treatment. It treats consent as a legal condition that must be preceded by adequate information, appropriate timing, and a real opportunity for the patient to understand the intervention and decide freely whether to accept it. The constitutional framework, the Patient Rights Regulation, the Turkish Code of Obligations, administrative procedure rules, and the Constitutional Court’s case-law all support that understanding. (Anayasa Mahkemesi)
The Turkish constitutional starting point is Article 17, which protects the individual’s material and spiritual existence and states that bodily integrity cannot be interfered with except under medical necessity and in cases prescribed by law, and that no person may be subjected to medical or scientific experiments without consent. That constitutional rule matters because it makes consent more than a hospital protocol. It elevates the issue to the level of a fundamental right. In parallel, Article 20 protects personal data and states that personal data may be processed only in cases envisaged by law or with the person’s explicit consent. Article 40 provides that damages caused by unlawful acts of public officials are compensated by the State, and Article 129 channels compensation suits arising from faults committed by public servants in the exercise of their duties against the administration rather than directly against the official. Together, these provisions explain why consent disputes in Turkey can trigger not only malpractice questions, but also privacy, public liability, and constitutional-rights analysis. (Anayasa Mahkemesi)
The patient-rights framework makes these constitutional principles concrete. The Patient Rights Regulation provides detailed rules on the scope of information to be given, the manner in which the patient must be informed, access to records, confidentiality, consent, refusal of treatment, consent forms, and the route for compensation claims when patient rights are violated. This is why informed consent in Turkey is not a narrow doctrine confined to surgery. It is part of a broader patient-rights regime that governs the legality of diagnosis, treatment, intervention, follow-up, and even the handling of health records. The Ministry of Health’s 2026 “Legal Responsibility Map” guide also places informed consent at the center of lawful medical intervention and identifies it as one of the four indispensable elements of a legally valid medical intervention, together with compliance with medical science, therapeutic purpose, and intervention by an authorized person. (pertekeih.saglik.gov.tr)
Under Turkish law, valid informed consent begins with information. Article 15 of the Patient Rights Regulation lists the core subjects on which the patient must be informed: the likely causes and course of the illness, who will perform the intervention and where and how it will be performed, other diagnostic and treatment options, the benefits and risks of those options, possible complications, the possible benefits and risks of refusal, the important features of the medicines to be used, lifestyle recommendations critical to health, and how further medical help may be accessed when necessary. This is a broad disclosure duty. It means Turkish law expects the patient to be informed not only of the planned intervention itself, but also of alternatives, foreseeable complications, and the consequences of saying no. (pertekeih.saglik.gov.tr)
The law is equally specific about how information must be delivered. Article 18 of the Patient Rights Regulation states that the information must be given as simply as possible, without ambiguity, in a way the patient can understand considering the patient’s social and cultural level. The same article says the patient is, as a rule, to be informed verbally by the healthcare professional who will perform the medical intervention, although another qualified healthcare professional may provide the information where circumstances make that necessary. The patient himself or herself is the primary addressee of the information, and outside emergency situations the patient must be given a reasonable amount of time before the intervention. Information must also be provided in an appropriate setting with the patient’s privacy protected. These details are significant because they show that Turkish law sees informed consent as a process, not a formality. (pertekeih.saglik.gov.tr)
That is exactly why a signed consent form is usually not enough by itself. Article 26 of the Regulation requires a consent form for interventions envisaged by legislation or for medical interventions that are medically likely to lead to dispute. The form must include the information required by Article 15, the information must also be conveyed verbally to the patient, the form must be signed in duplicate, one copy must stay in the patient file and the other must be delivered to the patient or legal representative, and the form must be signed by the professional giving the information and by the professional who will perform the intervention. The professional is responsible for the accuracy of the information given. The Ministry’s 2026 guide goes further and expressly says that a signed form alone is generally insufficient; what matters is that the patient was actually informed about risks, alternatives, expectations, and questions. (pertekeih.saglik.gov.tr)
The Constitutional Court has reinforced the same principle. In application no. 2015/10945, the Court stated that a patient’s consent may be deemed valid only when the patient has been duly informed and held that the lower courts had failed to address whether the applicants had been informed of the potential risks associated with normal delivery before giving consent. The Court emphasized that patients might change their decision when adequately informed of risks, which means the issue is not a mere paperwork defect but a defect going to the substance of autonomous decision-making. This case is especially important because it confirms that, in Turkish constitutional review, consent without adequate disclosure may not count as legally sufficient consent at all. (Kararlar Bilgi Bankası)
In practice, therefore, lack of informed consent can lead to liability even where the technical performance of the treatment is otherwise defensible. The Ministry’s 2026 guide expressly states that informed consent is one of the main elements of lawful medical intervention and that lack of adequate information may itself be treated as a rights violation. The same guide also explains that even when a complication is not, by itself, negligence, liability may still arise if the patient was not properly informed about complication risks or if the complication was mismanaged afterward. This is one of the most important realities of Turkish malpractice litigation: sometimes the provider loses not because the treatment choice was indefensible, but because the patient was never properly brought into the decision.
Turkish law also recognizes certain exceptions to the ordinary consent requirement, but those exceptions are limited. Article 24 of the Patient Rights Regulation states that patient consent is required for medical interventions, and that if the patient is a minor or under guardianship, permission is ordinarily taken from the parent or guardian. However, where the patient has no representative available, where the representative cannot be reached, or where the patient lacks the ability to express himself or herself, the law relaxes that requirement. Article 31 adds that where an intervention must be expanded during treatment because failing to do so would cause loss of an organ or loss of function, the intervention may be extended without additional consent in the presence of medical necessity. These rules show that Turkish law protects consent strongly, but not irrationally; genuine medical urgency remains an exception. (pertekeih.saglik.gov.tr)
At the same time, these emergency rules do not eliminate the need for documentation. Article 26 states that where a patient refuses an urgent medical intervention, the refusal must be taken in signed form or, if signature is refused, recorded in a formal report. The structure of the Regulation shows that emergency exceptions are not blank checks. The burden remains on the provider to show why immediate action was necessary, why prior consent could not realistically be obtained, and how the event was documented. In litigation, this often becomes decisive. An emergency that is well documented can support the defense. An emergency merely asserted after the fact may not. (pertekeih.saglik.gov.tr)
Consent issues are especially sensitive where the patient is a minor, a person under guardianship, or otherwise vulnerable. Article 24 says that even where legal-representative consent is sufficient, minors and restricted patients should still, to the extent they can understand the explanation, be involved in the information process and in decisions about their treatment. The same provision requires health institutions to take suitable measures to inform persons with disabilities appropriately and to obtain consent in a manner adapted to their condition. This means Turkish law is not satisfied with formal substitute consent alone. It also values the developing autonomy and practical participation of the patient wherever possible. (pertekeih.saglik.gov.tr)
Another important dimension is the right to refuse treatment. Article 25 of the Patient Rights Regulation provides that, except in legally mandatory situations, the patient may refuse the planned treatment or request that ongoing treatment be discontinued, provided the patient is informed of the possible consequences and a written record is obtained. The Regulation also says that the exercise of this right cannot later be used against the patient if the patient returns to the same health institution. This matters because informed consent is not only about the right to say yes. In Turkish law, it is equally about the right to say no after receiving proper disclosure. A provider who fails to explain the consequences of refusal may face legal difficulty later if a dispute arises about whether the patient truly made an informed choice. (pertekeih.saglik.gov.tr)
The consent regime is closely linked to access to records and confidentiality. Article 16 entitles the patient to inspect the file and records containing information about his or her health and to obtain copies, directly or through an authorized representative. Article 17 allows the patient to request completion, clarification, and correction of incomplete or inaccurate medical and personal data and to object to reports and request new reports. Article 23 states that information obtained because of the provision of healthcare may not be disclosed except where the law allows it, and that even disclosure based on consent does not remove liability if it effectively amounts to surrendering personality rights entirely or unjustifiably harms the patient. These rules matter in consent disputes because a provider who did not inform properly will often also struggle to defend the quality of the record. Poor documentation and defective disclosure usually travel together in malpractice files. (pertekeih.saglik.gov.tr)
Where lack of consent leads to harm, Turkish law provides more than one path to liability. In private-law settings, Article 49 of the Turkish Code of Obligations establishes the general rule that a person who unlawfully and culpably causes damage to another must compensate it. Articles 53 and 54 specify pecuniary damages in death and bodily injury cases, including treatment expenses, loss of earnings, diminished working capacity, and loss arising from impairment of economic future. Article 56 authorizes moral damages where bodily integrity has been violated and, in cases of severe injury or death, also for close relatives under the statutory conditions. In a consent-based malpractice dispute, these provisions allow the court to compensate both economic loss and non-economic harm flowing from an unauthorized or insufficiently authorized intervention.
The limitation structure also matters. Article 72 of the Turkish Code of Obligations provides that tort-based compensation claims become time-barred two years from the date the injured person learns of the damage and the liable person, and in all events ten years from the act itself, subject to any longer criminal limitation period. Article 146 provides the general ten-year limitation period unless the law provides otherwise. In informed-consent cases, these rules may become contentious because the patient may learn only later that the intervention carried undisclosed risks or that an alternative had never been properly explained. As a result, identifying when the patient actually learned the legally relevant damage can be as important as proving the medical facts themselves.
The public/private distinction changes the route of suit dramatically. In public-hospital cases, the Constitution and the Patient Rights Regulation direct compensation claims against the administration, not directly against the individual public physician. Article 43 of the Regulation states that when the defendant institution is a public institution, the claimant must follow Articles 12 and 13 of the Administrative Procedure Law. Article 13 requires an application to the administration within one year from learning of the harmful act and in any event within five years from the act itself; if the request is rejected or no answer is given within sixty days, suit may then be filed within the administrative litigation period. The Ministry’s 2026 guide also summarizes this public/private split by stating that malpractice claims involving public health institutions proceed against the administration in administrative court, whereas those involving private institutions and independent practitioners proceed in the judicial branch. (pertekeih.saglik.gov.tr)
In private healthcare disputes, the defendant structure is broader. Article 43 of the Patient Rights Regulation allows pecuniary and non-pecuniary claims against the institution employing the personnel, and on the private side the claim may be directed against the physician and/or the healthcare institution depending on the relationship. In addition, Law No. 6502 states that Consumer Courts are competent for disputes arising from consumer transactions and consumer-oriented practices, and Article 73/A makes mediation a precondition before filing suit in Consumer Court, subject to statutory exceptions. Because paid private medical services may fall within this framework depending on the structure of the relationship and the pleadings, informed-consent disputes in private hospitals and clinics can sometimes be litigated not only as malpractice cases, but also through a consumer-law procedural lens. (pertekeih.saglik.gov.tr)
International human-rights law also supports the Turkish approach. The Council of Europe’s Convention on Human Rights and Biomedicine, to which Turkey ratified the related treaty framework in 2017 with entry into force in 2018 according to the official status chart, provides that an intervention in the health field may be carried out only after the person concerned has given free and informed consent and that such consent may be freely withdrawn. While Turkish malpractice litigation is driven primarily by domestic law, this convention reinforces the idea that consent must be free, informed, and revocable, not merely documented. It fits comfortably with the Turkish constitutional and regulatory structure.
From a litigation perspective, the most persuasive consent-based malpractice cases in Turkey usually share the same features. They identify precisely what the patient was not told, tie that omission to Article 15 and Article 18 disclosure duties, show why the patient might reasonably have chosen differently if properly informed, and support the claim with records, witness statements, expert review, and the chronology of treatment. The Constitutional Court’s reasoning in application no. 2015/10945 is especially useful in this respect because it recognizes that the patient’s decision may have changed if the undisclosed risks had been explained. That reasoning turns inadequate disclosure into a causation issue, not just a formal defect. (pertekeih.saglik.gov.tr)
The practical lesson is simple but powerful. In Turkey, informed consent is not a box to be ticked after the medical decision has already been made. It is a legal and ethical dialogue that must occur before the patient’s bodily integrity is lawfully interfered with, except in narrowly defined emergencies. A provider who fails to explain the intervention, alternatives, material risks, likely complications, and the consequences of refusal may face liability even where no obvious technical error is proven. A provider who also fails to document that process properly, or treats the consent form as a substitute for real explanation, takes a much greater litigation risk. (pertekeih.saglik.gov.tr)
For patients, lawyers, hospitals, and physicians alike, the message of Turkish law is clear: lack of informed consent can lead to liability because consent is part of the very legality of the intervention. The legal question is not only whether the treatment was medically defensible, but whether the patient’s autonomy was respected in a way the Constitution, the Patient Rights Regulation, and Turkish liability law require. In Turkish Medical Malpractice Law, a well-performed procedure without valid informed consent may still create a serious legal problem. (Anayasa Mahkemesi)
Yanıt yok